Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.10
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
18.91%
Market Cap 29.19B
Revenue (ttm) 1.52B
Net Income (ttm) 9.32B
Shares Out 746.53M
EPS (ttm) 11.44
PE Ratio 3.42
Forward PE n/a
Dividend 0.71 (1.84%)
Ex-Dividend Date Oct 3, 2025
Volume 950,483
Average Volume 2,661,598
Open 39.10
Previous Close 39.10
Day's Range 39.05 - 39.50
52-Week Range 32.65 - 51.40
Beta 0.38
RSI 40.12
Earnings Date Apr 2, 2026

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.